Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
03 févr. 2022 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will...
Quotient Limited Announces Equity Awards
02 févr. 2022 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards...
Quotient Limited Provides MosaiQ Regulatory & Commercial Update
01 févr. 2022 08h40 HE
|
Quotient Limited
The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22First time attendance to Arab Health and Medlab Middle East 2022 in DubaiGenerated...
Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
31 janv. 2022 16h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third...
Quotient Limited Launches Scientific Advisory Board and Research Programs
26 janv. 2022 08h30 HE
|
Quotient Limited
MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countriesQuotient’s focus is to strengthen MosaiQ scientific...
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
15 déc. 2021 08h30 HE
|
Quotient Limited
Received feedback from the European notified body after review of Expanded IH submissionPleased with feedback and expect to submit a response to the questions in the next couple of weeksContinue to...
Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer
30 nov. 2021 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced Mr. Esteban Uriarte as the Company’s Chief...
Quotient Limited Announces Equity Awards
19 nov. 2021 08h20 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards...
Quotient Limited Provides Second Quarter Fiscal 2022 Results
15 nov. 2021 18h57 HE
|
Quotient Limited
Alba by Quotient: Revenues exceeded guidance; Achieved year-over year growth in Q2 FY 2022 of 15.9%Financial Position: Available cash & short-term investments of $141.8 millionBusiness Update:...
Quotient Limited to Participate in the Jefferies London Healthcare Conference
12 nov. 2021 16h15 HE
|
Quotient Limited
JERSEY, Channel Islands, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the management team will present at...